TLIS
Talis Biomedical Corporation Common Stock
TLIS
TLIS
Delisted
TLIS was delisted on the 30th of August, 2024.
19 hedge funds and large institutions have $4.27M invested in Talis Biomedical Corporation Common Stock in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 7 closing their positions.
Holders
19
Holders Change
-3
Holders Change %
-13.64%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
11
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
BBA
1
Baker Bros. Advisors
New York
|
$2.93M |
| 2 |
GC
2
Greenlight Capital
New York
|
$860K |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$177K |
| 4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$64.9K |
| 5 |
5
BlackRock
New York
|
$28.4K |
